BC
GSK icon

Brookfield Corp’s GSK GSK Stock Holding History

Brookfield Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-644,249
Closed -$23M – 291
2023
Q2 		$23M Buy
644,249
+39,429
+7% +$1.41M 0.09% 82
2023
Q1 		$21.5M Buy
604,820
+570,527
+1,664% +$20M 0.08% 99
2022
Q4 		$1.21M Sell
34,293
-43
-0.1% -$1.43K ﹤0.01% 480
2022
Q3 		$1.01M Sell
34,336
-346,516
-91% -$13.1M ﹤0.01% 532
2022
Q2 		$20.7M Buy
380,852
+135,647
+55% +$7.49M 0.09% 90
2022
Q1 		$13.4M Buy
245,205
+166,192
+210% +$9.03M 0.05% 125
2021
Q4 		$4.36M Buy
+79,013
New +$4.11M 0.02% 238

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brookfield Corp's GSK Position: Q3 2023 in Review

Brookfield Corp sold out of GSK (GSK) in Q3 2023, closing a stake of 644,249 shares — an estimated $23M sold.

Brookfield Corp first reported a position in GSK in Q4 2021 and held it in 7 quarters. The position peaked at $23M in Q2 2023. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Brookfield Corp reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 644,249 GSK shares in Q3 2023, an estimated $23M.
  • Brookfield Corp first reported a position in GSK in Q4 2021 and held it in 7 quarters.
  • Brookfield Corp's GSK position peaked at $23M in Q2 2023.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.